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NF-κBSepsis caused by LPS is characterized by an intense systemic inﬂammatory response affecting the lungs, causing
acute lung injury (ALI). Dysfunction of mitochondria and the role of reactive oxygen (ROS) and nitrogen species
produced bymitochondria have already been proposed in the pathogenesis of sepsis; however, the exact molec-
ular mechanism is poorly understood. Oxidative stress induces cyclophilin D (CypD)-dependent mitochondrial
permeability transition (mPT), leading to organ failure in sepsis. In previous studies mPT was inhibited by cyclo-
sporine Awhich, beside CypD, inhibits cyclophilin A, B, C and calcineurin, regulating cell death and inﬂammatory
pathways. The immunomodulatory side effects of cyclosporine A make it unfavorable in inﬂammatory model
systems. To avoid these uncertainties in the molecular mechanism, we studied endotoxemia-induced ALI in
CypD−/−mice providing unambiguous data for the pathological role of CypD-dependent mPT in ALI. Our key
ﬁnding is that the loss of this essential protein improves survival rate and it can intensely ameliorate
endotoxin-induced lung injury through attenuated proinﬂammatory cytokine release, down-regulation of
redox sensitive cellular pathways such asMAPKs, Akt, and NF-κB and reducing the production of ROS. Functional
inhibition of NF-κB was conﬁrmed by decreased expression of NF-κB-mediated proinﬂammatory genes. We
demonstrated that impaired mPT due to the lack of CypD reduces the severity of endotoxemia-induced lung in-
jury suggesting that CypD speciﬁc inhibitors might have a great therapeutic potential in sepsis-induced organ
failure. Our data highlight a previously unknown regulatory function of mitochondria during inﬂammatory
response.
© 2015 Published by Elsevier B.V.1. Introduction
Sepsis is a severe systemic inﬂammatory process caused by bacterial
agents, such as lipopolysaccharide (LPS). LPS plays a crucial role in the
induction of inﬂammatory responses and acute lung injury (ALI), lead-
ing to acute respiratory distress syndrome (ARDS) [1,2]. The binding
of LPS to toll-like receptor (TLR) 4 initiates signaling pathways, culmi-
nating in the activation of mitogen-activated protein kinases (MAPK)
and NF-κB [3,4]. As a consequence of NF-κB activation, the expression
of cytokines and chemokines is up-regulated, causing neutrophil inﬁl-
tration into the lung [5,6,7]. Leukocytes produce reactive oxygen species
(ROS) and nitrogen monoxide (NO), in order to eliminate pathogens.istry and Medical Chemistry,
Pecs, Hungary.However, the excessive production of these reactive agents can damage
cellular components and lead to epithelial and endothelial cell death
and tissue damage. LPS-induced ROS can further enhance the activity
of redox-sensitive inﬂammatory transcription factors and signaling
kinases such as MAPKs and Akt [8–11].
Cytosolic Ca2+ overload or ROS can trigger the opening ofmitochon-
drial permeability transition (mPT) pore leading to the collapse of ATP
production, release of proapoptotic molecules and initiating further
ROS production. Cyclophilin D (CypD), a matrix peptidyl-prolyl cis-
trans-isomerase, encoded by the nuclear Ppif gene, is a modulator of
mPT although the exact molecular composition of the pore is still
under debate [12,13]. Studies with mitochondria lacking CypD demon-
strated very low Ca2+-sensitivity and delayedmPT pore opening, clearly
favoring an indispensable modulatory role of CypD [14,15,13]. The
generally used inhibitor of mPT is cyclosporine A (CsA) [16] which in-
hibits, not only CypD, but also cyclophilin A, B, C and calcineurin, there-
fore has a wide range of signaling effects — including inﬂammatory
Fig. 1.Mice lacking CypD survive lethal endotoxemia. Survival studywas carried out with
age-matched wild-type (n = 8) and CypD knock-out mice (n = 8). Survival was moni-
tored for 7 days, after 40 mg/kg intraperitoneal LPS administration.
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effects of CsA make it unfavorable for investigating the role of mPT
under inﬂammatory conditions. The role of mPT has been implicated
in many pathological conditions accompanied by oxidative damage;
however, there are only a few studies regarding the role of mPT in in-
ﬂammatory processes, and no experiment has been conducted to
date to evaluate its participation in ALI. Here, we give the ﬁrst speciﬁc
evidence for the role of CypD-dependent mPT in ALI using CypD
knock-out mice.
2. Materials and methods
2.1. Ethics statement
Animal experiments were performed according to Hungarian Gov-
ernmental Regulation 40/2013. (II. 14.) in accordance to the Directive
2010/63/EU of the European Parliament and of the Council on the pro-
tection of animals used for scientiﬁc purposes. The licensewas approved
by the County Governmental Ofﬁce (No. BA02/2000–20/2011) lasting
for ﬁve years (2013–2017).
2.2. Animals
Male C57BL/6 mice were from Charles River Hungary Breeding
and genetically engineered homozygous male Ppif−/− cyclophilin D
knock-outmicewith C57BL/6 backgroundwere supplied by Prof. László
Tretter (Semmelweis University, Budapest, Hungary). The mice were
kept under standard conditions.
2.3. Materials
LPS from Escherichia coli 0127:B8 and all materials that are not
speciﬁed elsewhere were purchased from Sigma-Aldrich (St. Louis,
MO). Anti-phospho-p44/42, anti-p44/42, anti-phospho-Akt, anti-Akt,
anti-phospho-p38, anti-p38, anti-phospho-JNK, anti-JNK, anti-phospho-
NF-κB p65, anti-NF-κB p65, anti-phospho-IκBα and anti-IκBα primary
antibodies for immunoblotting were from Cell Signaling Technology
(Danvers, MA), anti-MKP-1, anti-4-hydroxy-2-noneal Michael adducts,
anti-nitrotyrosine and anti-GAPDH antibodies were from Millipore
(Billerica, MA).
2.4. ALI model and survival study
To induce murine endotoxemia, intraperitoneal LPS (40 mg/kg,
dissolved in PBS) was given, control groups received PBS (10 μl/g).
Primarily survival study was performed with age-matched wild type
(n = 8) and CypD knock-out mice. Mice were monitored for clinical
signs of endotoxemia and lethality every hour for 96 h, after that they
were monitored 3 times a day till the end of the ﬁrst week. No late
deaths were observed in any of the experimental groups. Alternatively,
24 h after treatment the mice were anesthetized with isoﬂurane
(Isopharma). Lungs were removed, and processed as follows: the right
upper lobe was ﬁxed in 10% paraformaldehyde, except for a piece
whichwas put into primary ﬁxative (2% paraformaldehyde/2% glutaral-
dehyde) for electronmicroscopy; the right lower lobeswere snap frozen
in liquid N2; the left upper lobe was put into RNAlater RNA stabilization
reagent (Qiagen, Hilden, Germany); the left lower lobe lung homoge-
nate was prepared as described later.
2.5. Western blot analysis
10mgof frozen tissuewas homogenized (50mMTRIS, 50mMEDTA,
50 mM sodium metavanadate, 0.5% protease inhibitor cocktail, 0.5%
phosphatase inhibitor cocktail, pH= 7.4) and the protein concentra-
tion was determined with a DC™ Protein Assay kit (Bio-Rad, Hercules,
CA). Western blotting was performed as described previously [9].Peroxidase labeling was visualized with the Pierce ECLWestern blot-
ting Substrate (Thermo Scientiﬁc, Waltham, MA) detection system.
Quantiﬁcation of band intensities of the blots was performed by
ImageJ software.
2.6. Cytokine determination by ELISA from lung homogenate
After removal of the left lower lobe, the tissue was rinsed in ice-cold
PBS and homogenized. Protein concentration was determined with
DC™ Protein Assay kit (Bio-Rad). TNFα, IL-1β and IL-10 concentrations
were measured with ELISA Ready-SET-Go! (eBioscience, San Diego,
CA): 200 μg protein/well was used, the cytokine-amountwas expressed
in optical density at 450 nm.
2.7. mRNA isolation from lung tissue and quantitative RT-PCR
RNA was isolated from tissue samples kept in RNALater (Qiagen)
solution using TRIzol reagent (Invitrogen, Grand Island, NY). Total RNA
concentration was determined using spectrophotometric method
(IMPLEN NanoPhotometer™, München, Germany) and reverse-
transcribed into cDNA with MMLV RT/RevertAid™ First Strand cDNA
Synthesis Kit (Fermentas, Burlington, Canada). RT-PCR was performed
with 1 μl of cDNA in MiniOpticon Real-Time PCR System (Bio-Rad)
using SYBR Green Supermix kit (Bio-Rad). Speciﬁc primers against
CD14, IL-1α, Cxcl2, IFN-γ, iNOS, TNFα and actin were used. The relative
gene expression was calculated with ΔΔCt method using BIO-RAD CFX
Manager software.
2.8. Pulmonary histopathology
The paraformaldehyde ﬁxed superior lobe of the right lung was
embedded in parafﬁn and cut into 5 μm sections. Hematoxylin-eosin
staining was performed using standard protocol. Slides were scored in
a double blindedmanner by an independent expert using the scoring
system described previously [21]. Five slides in each group were
assessed under high power ﬁeld and evaluated for intra-alveolar
and interstitial neutrophil accumulation, presence of proteinaceous
debris and hyaline membrane, and also alveolar wall thickening.
2.9. Immunohistochemistry
The lung tissue sections were probed with antibodies against 4-
hydroxy-2-noneal Michael adducts and nitrotyrosine. Formalin-
ﬁxed, parafﬁn-embedded 5 μm tissue sections were deparafﬁnized
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°C heat exposure for 20 min. Sections were incubated in primary an-
tibody over-night. Blocking and staining procedures were performed
with Dako EnVision™ FLEX detection system with Dako Autostainer
Plus instruments (Glostrup, Denmark). All sections were counter-
stained with hematoxylin.
2.10. Electron microscopy
Tissue samples were rinsed in 0.1 M phosphate buffer then
ﬁxed in 2% glutaraldehyde/2% paraformaldehyde for 3 h. After
a post-ﬁxation step (osmium tetraoxide 1% in 0.1 M phosphate
buffer) samples were dehydrated and embedded into DurcupanFig. 2. Deletion of CypD prevents lung vascular permeability, edema, and inﬂammation induc
(A) and LPS-treated (C)wild typemice, as well as fromuntreated (B) and LPS-treated (D) CypD
in LPS-treated wild type (E) and knock-out mice (F). Arrows pointing on marginating and tran
perivascular edema. Original magniﬁcation was 10× (A,B,C,D) and 40× (E,F). Scale bars repres
to the recommendations of the American Thoracic Society (G). Results are presented as mean ±
indicated by ±(p b 0.001), signiﬁcant difference between LPS-treated wild type and CypD knoepoxy resin. Serial ultrathin sections were cut and collected on
cupper grids, then passed onto drops of uranyl acetate, later on
lead citrate. Following the routine counterstaining samples were
rinsed in distilled water and dried. Samples were observed and
documented with JEOL 1200 (Tokyo, Japan) transmission electron
microscope.2.11. Statistical analysis
Comparisons between experimental groups were made by
one-way ANOVA and post-hoc test. Data represent mean ± SEM. A
value of p b 0.05 was considered statistically signiﬁcant.ed by LPS. Representative pathological and histological analysis of lungs from untreated
knock-outmice. Enlarged lightmicroscopic images highlight differences of vascular events
smigrating leukocytes, arrowheads indicate severe endothelial leakage with consequent
ent 100 μm. Histological scoring was also performed in double blinded manner according
SEM, n = 5. Signiﬁcant difference between control and LPS-treated wild type animals is
ck-out animals is indicated by *(P b 0.05).
Fig. 3. Lack of CypD prevents the ﬁne structural anatomy of lung tissue damaged by LPS. (A) In untreated wild type mice blood vessel endothelial cells (ec) attach intact basement mem-
brane (bm). Dense layer ofﬁbro elastic membrane supports interseptal wall (arrow). er: erythrocyte, cl: collagenﬁbers. (B) In CypD knock-outmice intact basementmembrane (bm) and
endothelial cell (ec) are visible. Prominent ﬁbro elastic layer (arrow) lying beneath basement membrane. (C, D) LPS-treated wild type mice show seriously degenerating portion of an
endothelial cell (ec) with large vacuoles appearing in cytoplasm (arrows, C) and thinner basement membrane (bm). Number and size of pinocytotic vesicles (stars) are increased, cyto-
plasm is swollen. Widened inter endothelial junction (circle) is also shown. Portions of endothelial cells are focally detached from basal membrane (arrows, D). Denuded patches serve
potential surfaces to ﬁne ﬁbrin branches (fb) to attach. Blood vessel lumen is congested with platelets (pl). (E, F) In CypD knock-out LPS-treated mice the structure of blood vessel
walls is almost identical with that of control animals. Intact endothelial cell (ec) basement membrane (bm) and ﬁbro elastic membrane (arrow, E) are shown. Diffuse appearance of
collagen ﬁbers (cl) could also be observed. In some cases intact endothelial cell (ec) portionswere seen focally detached (arrow, F) from basementmembrane (bm). Cytoplasmic swelling
could not be seen. (G, H) Fine structure of endothelial cells show nomorphological changes between CypD+−+ vs CypD−/−. (I, J) Serious endothelial cytoplasmic degeneration is visible
(arrow, I) in LPS-treated wild type compared to knock-out mice. (K, L) Dense membrane sections of inter endothelial junctions (arrows) in blood vessel walls are intact both in wild type
and CypDknock-out control animals. (M,N) Arrows showwidened and intact thigh junctions in blood vesselwall of LPS-treatedwild type and CypDknock-out animals, respectively. Scale
bars: 500 nm.
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Fig. 4. Loss of CypD protects the lung epithelial cells against oxidative damage. Immunohistochemical staining of mouse lungs for nitrotyrosine (A) and for 4-hydroxy-2-noneal Michael
adducts (B) in lung tissue counterstainedwith hematoxylin. Endothelia of lung vessels in LPS-treatedwild typemicewere intensively stained compared to CypDknock-outmice. Epithelial
cells showed prominent positivity inwild type, but not in knock-out LPS-treated animals. Star indicates airway lumenwith strong positivity of bronchial cells and secretory product. Scale
bar represents 100 μm.
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Fig. 5. Effect of LPS on cytokine production of wild type and CypD−/−mice. Determination of proinﬂammatory cytokines TNFα (A) and IL-1β (B), and anti-inﬂammatory cytokine IL-10
(C) 24 h after LPS-treatment from total lung homogenates by ELISA. Bars represent mean ± SEM of optical densities, n = 4. Signiﬁcant difference between control and LPS-treated wild
type animals is indicated by ±(p b 0.05), signiﬁcant difference between LPS-treated wild type and CypD knock-out animals is indicated by *(P b 0.05).
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3.1. Mice lacking CypD survive lethal endotoxemia
CypD knock-out animals exhibited improved survival rate after
intraperitoneal high dose LPS treatment compared to wild type
mice. Out of the 8 CypD−/−mice two (25%) died within the ﬁrst
30 h but after that no deaths occurred. However all of the 8 wild
type mice died within 60 h (Fig. 1). These results show that the loss
of CypD massively reduces mortality.3.2. CypD knock-out mice are protected against LPS-induced
histopathological changes
Histological examination revealed severe lung injury in LPS-treated
wild type animals. On hematoxylin-eosin stained sections, alveolar
wall thickening, blood vessel congestion and perivascular exudation
were seen, which are suggestive of impaired tissue architecture and
function,while robust interstitial neutrophil inﬁltration indicated ongo-
ing immune response (Fig. 2C). Interstitial accumulation of neutrophils
was markedly decreased in LPS-treated CypD−/−mice (Fig. 2E, 2F).
Other pathological changes like alveolar widening and perivascular
edema were also signiﬁcantly milder in CypD−/− lungs and no throm-
botic event could be observed despite moderate congestion (Fig. 2D).
Lungs of control animals in both groups had normal tissue architecture
with thin alveolarwalls, occasional intra-alveolar macrophages and fewneutrophils (Fig. 2A, 2B). For making histological examination quantita-
tive a scoring was performed as described earlier (Fig. 2G). Scores were
signiﬁcantly higher in the LPS-treatedwild typemice compared to CypD
knock-outsmainly resulting frommarked differences in interstitial neu-
trophil accumulation and alveolar thickening.3.3. Lack of CypD prevents the ﬁne structural anatomy of lung tissue
damaged by LPS
LPS treatment induced serious lesions in the lung tissue of wild type
mice. Endothelial cells were swollen loaded with cytoplasmic vacuoles
and the number of pinocytotic vesicles was increased (Fig. 3C, 3I).
Inter-endothelial connections of endothelial cells were damaged or di-
lated (Fig. 3M). An impaired, leaky endothelial layer of blood vessels
allowed extravasation of intravascular ﬂuid resulting in tissue edema.
Another sign of impaired blood vessel functioning was a detached
basal membrane with an unsettled ﬁbroelastic layer in the alveolar
septa (Fig. 3D). These denuded surfaces are potential targets of ﬁbrin at-
tachment and hyaline membrane formation. The proinﬂammatory ac-
tivity of ﬁbrin fragments and massive liberation of immune cell
molecules may explain the appearance of a considerable amount of
cell debris. Obvious thickening of the alveolar septa by accumulated
connective tissue indicates strong ﬁbrosis (Fig. 3D). Tissue organization
of CypD−/−micewith or without LPS treatmentwas almost identical to
that of wild type untreated animals (Fig. 3A, 3B, 3G–L). The level of sep-
tal thickening was not comparable to that in wild type LPS-treated
Fig. 6.Deﬁciency of CypDaffectsMAPKs,MKP-1 andAkt inmouse lungs after LPS treatment. Activation of ERK (A), p38 (B), SAPK/JNK (C),MKP-1 (D) andAkt (E) in lung total homogenates
was determined 24 h after LPS treatment by immunoblotting utilizing phosphorylation speciﬁc and total primary antibodies. Total proteins (non-phosphorylated) and GAPDHwere used
as loading controls. A representative blot aswell as a bar diagramof the quantiﬁed blots are presented. Bars representmean±SEMof pixel densities, n=4. Signiﬁcant difference between
control and LPS-treated wild type animals is indicated by ±(p b 0.05), signiﬁcant difference between LPS-treated wild type and CypD knock-out animals is indicated by *(p b 0.05).
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of acute lung tissue lesions or much milder tissue injury.
3.4. Loss of CypD protects lung epithelial cells against oxidative damage
Lung tissue sections were examined with immunohistochemistry
using antibodies against nitrotyrosine, and 4-hydroxy-2-noneal Mi-
chael adducts. LPS treatment markedly enhanced immunohistochemi-
cal staining in endothelial and lung epithelial cells of wild type
animals. Endothelial and epithelial cells of CypD−/−mice showed less
intense staining (Fig. 4A). The extensive lipid-peroxidation damage
after LPS treatment in wild type animals was also visible regarding
bronchial mucinosus cells. In contrast, endotoxemic CypD−/−mice ex-
hibited a markedly reduced staining of endothelial tissue, while the in-
tensity of epithelial positivity was almost the same as in wild type and
knock-out animals without LPS treatment (Fig. 4B).
3.5. Absence of CypD impairs proinﬂammatory, but does not affect anti-
inﬂammatory cytokine production
During ALI, early phase cytokines promote the production of
chemokines by resident cells to enhance neutrophil sequestration into
the lung. Clinical studies have proven the importance of these factors,
since the outcome of patients with ARDS signiﬁcantly correlates with
the concentration of these cytokines in bronchoalveolar lavage ﬂuid
[7,21,22]. In our experiments, LPS treatment resulted in elevated TNFα
and IL-1β levels, measured in lung homogenates, while the amount of
these cytokines was markedly decreased in LPS-treated CypD−/−mice
(Fig. 5A, 5B). IL-10, responsible for limiting inﬂammatory processes,
ameliorates endotoxemia-induced ALI and high levels in the lungs of
patients suffering from ARDS correlated with better outcome [23,24].
In our study, there was no difference in the amount of anti-
inﬂammatory IL-10 in total lung homogenates between wild type and
knock-out animals 24 h after LPS administration (Fig. 5C), as both in-
creased signiﬁcantly.
3.6. Deﬁciency of CypD affects the activation of MAPKs through MKP-1 and
Akt in mouse lungs after LPS treatment
Phosphorylation and activation of MAPKs was shown to play an im-
portant role in the development of ALI following LPS exposure [25,26].Fig. 7. CypD is required for LPS-induced NF-κB activation. Phosphorylation of NF-κB (A) and IκB
ting, utilizing phosphorylation speciﬁc primary antibodies. Total proteins (non-phosphory
diagram of the quantiﬁed blots are presented. Bars represent mean ± SEM of pixel densiti
indicated by ±(p b 0.001), signiﬁcant difference between LPS-treated wild type and CypDIn our experiments, phosphorylation levels of extracellular signal-
regulated kinase (ERK), p38, and c-Jun. N-terminal kinase (JNK) were
signiﬁcantly elevated 24 h after LPS treatment in wild type animals,
while the activation of ERK and p38 was lower in the lungs of LPS-
treated CypD−/−mice (Fig. 6A, B). No difference could be observed in
JNK phosphorylation between knock-out and wild type animals after
LPS challenge (Fig. 6C).
MAP kinases are under the direct negative regulation through
dephosphatase activity of MAPK-phosphatase-1 (MKP1). The level of
MKP1 was up-regulated in CypD−/−mice compared to wild type ani-
mals after LPS treatment (Fig. 6D).
Beside MAP kinases Akt contributes to the TLR4 signaling cascade
leading to NF-κB activation and promoting inﬂammatory processes in
the lung. In our experiment, LPS treatment signiﬁcantly enhanced the
phosphorylation of Akt in the lungs of wild type animals, while this
effect was strongly reduced in CypD−/− animals, resulting in a phos-
phorylation level that was comparable to that seen in control animals
(Fig. 6E).
3.7. CypD knock-out mice do not exhibit prominent NF-κB activation after
LPS treatment
We determined the phosphorylation level of the p65 subunit of
NF-κB and inhibitory-κB (IκB). LPS caused a signiﬁcant activation of
NF-κB in wild type mice compared to CypD−/− animals (Fig. 7A).
Similarly, robust IκB phosphorylationwas found in wild type animals
after LPS treatment; however, CypD−/− mice showed decreased
phosphorylation, which seems to conﬁrm our data regarding NF-κB
activation (Fig. 7B).
3.8. Marked differences between wild type and CypD knock-out animals
regarding NF-κB-mediated gene expression
To gain further insight into the functional inhibition of NF-κB, we
determined the gene expression of NF-κB-regulated inﬂammatory
mediators that are crucial in the pathophysiology of LPS-induced
ALI using qRT-PCR. Expression of CD14, CXCl2, IFNγ, TNFα, IL-1 and
inducible NO synthase (iNOS) was elevated in LPS-treated wild
type animals; this LPS-induced overexpression was strongly reduced
in every case in the knock-out mice. Our data show that NF-κB regula-
tion in CypD−/− animals is not limited to the level of phosphorylation(B) in lung total homogenates was determined 24 h after LPS treatment by immunoblot-
lated) and GAPDHwere used as loading controls. A representative blot as well as a bar
es, n = 4. Signiﬁcant difference between control and LPS-treated wild type animals is
knock-out animals is indicated by *(P b 0.05).
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genes as well (Fig. 8).
4. Discussion
In the present study, we demonstrated that a deﬁciency of CypD
ameliorates pathological consequences of endotoxemia-induced ALI,
both at the tissue andmolecular levels, andmassively reducesmortalityFig. 8. CypD regulates LPS-inducedNF-κB-mediated gene expression. The expression of NF-κB-m
(F) was determined 24 h after LPS treatment in lung tissue by RT-PCR. Actinwas used as a house
controls. Results are presented as mean ± SEM, n = 4. Signiﬁcant difference between control
tween LPS-treated wild type and CypD knock-out animals is indicated by *(P b 0.05).rate. Cyclophilins are ubiquitous proteins differing in their subcellular
localization and binding afﬁnity to CsA. CsA inhibits calcineurin thereby
suppresses MKP-1 expression resulting in increased MAPK activation
[27]. Therefore, considering the importance of MAPKs in NF-κB activa-
tion, CsA is obviously unsuitable for studying the effect of mPT impair-
ment on LPS-induced inﬂammatory response. To resolve this problem
and to focus on the role of CypD andmPT on LPS-induced inﬂammation,
we used a CypD−/−model.ediated inﬂammatory genes, CD14 (A), IFN-γ (B), TNFα (C), IL-1α (D), Cxcl2 (E) and iNOS
keeping gene to generate theΔCt values. Data were normalized toΔCt values of untreated
and LPS-treated wild type animals is indicated by ±(p b 0.001), signiﬁcant difference be-
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dant–antioxidant imbalance in many organs, severely affecting the
lungs. Lung epithelial cells and macrophages, as well as sequestered
neutrophils produce excessive amounts of ROS, amplifying oxidant
events. Mitochondrial ROS production-induced cellular damage has
been implicated in the pathophysiology of LPS-induced inﬂammation
and ALI [28] characterized by endothelial barrier dysfunction, intersti-
tial edema and thickening, epithelial damage, and the accumulation of
neutrophils. Our histological results showed the same characteristics
in the lungs of LPS-challenged wild type mice, but animals lacking
CypD showed only mild tissue injury. Histological scores supported
these ﬁndings. The deleterious effect of ROS on endothelial and epithe-
lial morphology and barrier function has been demonstrated at the sub-
cellular ﬁne structural level using electron microscopy; however, a
deﬁnitive protective effect was found in CypD-deﬁcient mice. Our re-
sults suggest that the loss of CypD greatly diminishes ROS and RNS pro-
duction after LPS treatment with the consequent attenuation of
microscopic and subcellular pathological changes and oxidative tissue
damage in the lungs of mice.
ROS contribute to the inﬂammatory phenotype, with the increased
production of proinﬂammatory cytokines in lung cells. Elevated concen-
trations of proinﬂammatory chemokines and cytokines, including IL-8,
IL-1β, and TNFα, in the lungs are critical regulators of the outcome of
ALI. Compared to wild type animals, in CypD-deﬁcient mice, the level
of TNFα and IL-1β produced by resident cells was decreased, indicating
that the lack of CypD could severely interfere with cytokine generation,
possibly due to reducedmitochondrial ROS production. This strong cor-
relation between mitochondrial ROS and proinﬂammatory cytokine
production was also reported by Bulua and his coworkers, pointing to
the fact that the blockade of mitochondrial ROS generation efﬁciently
reduces inﬂammatory cytokine production after treatment in cells
from patients with TNF receptor-associated periodic syndrome and
from healthy individuals [29].
As a counterbalance, IL-10 is a key anti-inﬂammatory cytokine in the
down-regulation of inﬂammatory response. One of its key functions is
regulation of the pathogen-mediated activation of macrophages and
dendritic cells, consequentially inhibiting the expression of chemokines,
inﬂammatory enzymes, and potent proinﬂammatory cytokines. Elevat-
ed levels of IL-10 after LPS exposure did not differ in the two LPS-treated
groups, indicating that the ameliorated inﬂammatory processes in
CypD-deﬁcient animals are not a consequence of anti-inﬂammatory
mechanisms but of attenuated ROS production.
ROS are important chemicalmediators that regulate signal transduc-
tion pathways, includingmembers of theMAP kinases. In linewith pre-
vious studies, [25,26] we found the increased phosphorylation of
MAPKs in the lungs after LPS treatment. Phosphorylation of redox-
sensitive p38 and ERK was markedly decreased in CypD-deﬁcient
mice; however, JNK activation was unaltered in our experiments. Al-
though ROS could activate all three MAPKs, this regulation is conducted
by different upstream regulators independently of each other. It was
previously reported that H2O2 stimulates JNK but not p38 and ERK via
a pathway that is dependent on Src; however, the exact mechanisms
for ROS-mediated p38 and ERK activation remain unknown [30].
Based on our results the depletion of CypD exerts its effect on ROS-
induced MAPK activation in p38- and ERK-dependent and JNK-
independent ways. Besides the regulation of upstream mediators of
MAPKs, direct control mechanisms could act also through MKP-1 activ-
ity. MKP-1 is a central redox sensitive regulator of ERK and p38 during
endotoxemia, ameliorating monocyte activation and consequential
lung injury [31,11]. Up-regulation of MKP-1 in CypD knock-out mice
upon LPS exposure represents a strong protective pathway due to the
attenuated activation of ERK and p38. Previous studies have shown
that p38 is regulated by Akt as well, positively inﬂuencing NF-κB activa-
tion [32]. Indeed, the phosphorylation pattern of p38 followed that of
Akt in our experiments. Since Akt could be activated by ROS [33] and
IL-1β [32], a lack of CypD could down-regulate the Akt-p38-NF-κBpathway through these inﬂammatory mediators. In accordance with
these ﬁndings, NF-κB and IκB phosphorylation increased dramatically
after LPS treatment in the lungs of wild type but not CypD-deﬁcient an-
imals. Moreover, we proved the functional inhibition of NF-κB activity
in the absence of CypD, analyzing NF-κB-related genes at the mRNA
and protein levels. In CypD-deﬁcient mice, the expression of important
participants of TLR4 signaling (CD14, iNOS) and mediators of ALI, like
chemokines and cytokines (Cxcl2, IFNγ, TNFα, IL-1α), showed a signif-
icant decrease compared towild type animals. Our gene expression data
suggest that the downregulation of NF-κB and the related genes by the
lack of CypDmay be essential to prevent or treat inﬂammatory diseases.
In summary, we demonstrate that the loss of essential mPTmodula-
tory protein CypD can intensely ameliorate endotoxemia-induced lung
injury in mice through down-regulation of the NF-κB pathway, inﬂam-
matory mediators and reducing the production of ROS. Our data high-
light a previously unknown regulatory function of mitochondria due
to the mediation of mPT during inﬂammatory responses. This ﬁnding
offers a valuable therapeutic target in conditions of acute inﬂammation
including ALI.Conﬂict of interest
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